UBS Group’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,477
Closed -$31.8K 9338
2024
Q3
$31.8K Buy
8,477
+8,474
+282,467% +$31.8K ﹤0.01% 5898
2024
Q2
$30 Sell
3
-76
-96% -$760 ﹤0.01% 8111
2024
Q1
$6.01K Buy
79
+76
+2,533% +$5.78K ﹤0.01% 6318
2023
Q4
$565 Buy
3
+2
+200% +$377 ﹤0.01% 7369
2023
Q3
$410 Hold
1
﹤0.01% 7367
2023
Q2
$2.75K Hold
1
﹤0.01% 6624
2023
Q1
$1.54K Sell
1
-2
-67% -$3.08K ﹤0.01% 7613
2022
Q4
$6.63K Sell
3
-3
-50% -$6.63K ﹤0.01% 7815
2022
Q3
$24K Buy
6
+5
+500% +$20K ﹤0.01% 6079
2022
Q2
$2K Hold
1
﹤0.01% 8608
2022
Q1
$3K Sell
1
-10
-91% -$30K ﹤0.01% 8453
2021
Q4
$70K Buy
11
+10
+1,000% +$63.6K ﹤0.01% 5542
2021
Q3
$7K Buy
+1
New +$7K ﹤0.01% 7197
2021
Q2
Sell
-2
Closed -$43K 8675
2021
Q1
$43K Buy
+2
New +$43K ﹤0.01% 5697
2020
Q4
Hold
0
7706
2020
Q3
Sell
-1
Closed -$4K 7468
2020
Q2
$4K Sell
1
-2
-67% -$8K ﹤0.01% 6628
2020
Q1
$6K Buy
+3
New +$6K ﹤0.01% 6325
2019
Q4
Hold
0
7233
2019
Q3
Hold
0
7216
2019
Q2
Hold
0
-$3K 7191
2019
Q1
Hold
0
-$7K 6522
2018
Q4
Hold
0
-$2K 6502
2018
Q3
Hold
0
6830
2018
Q2
Hold
0
7204
2018
Q1
Hold
0
-$1K 7110
2017
Q4
Hold
0
6753
2017
Q3
Hold
0
-$9K 6938
2017
Q2
Hold
0
-$1K 5910
2017
Q1
Hold
0
6543
2016
Q4
Hold
0
-$1K 6935
2016
Q3
Hold
0
-$1K 6597
2016
Q2
Hold
0
-$13K 6652
2016
Q1
Hold
0
-$2K 5662
2015
Q4
Hold
0
-$4K 6604
2015
Q3
Hold
0
-$2K 6391
2015
Q2
Hold
0
-$6K 6569
2015
Q1
Hold
0
-$10K 6126
2014
Q4
Hold
0
6005